Search

Search results

10 results found

Pan Group

The Pan Group in the Stanley Center for Psychiatric Research focuses on translating emerging human genetics into biological insights that can be turned into potential novel therapeutics for major psychiatric illnesses including schizophrenia and bipolar disorders.

Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome

Hwang, Hongik, Matthew J. Szucs, Lei J. Ding, Andrew Allen, Xiaobai Ren, Henny Haensgen, Fan Gao, et al. 2021. “Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome”. Biological Psychiatry 89 (3): 256-69.

Lei A Wang, Ph.D.

Lei is an interdisciplinary scientist with skills in neuroscience, machine learning, and software development. He received his PhD in Pharmacodymamics (with a focus on Neuroscience) from University of Florida. He completed his postdoctoral training in neurophysiology at University of North Texas...

Juan Lorenzo "Juanchi" Pablo, Ph.D.

Juanchi is an electrophysiologist and cell biologist with a particular interest in the regulation of ion channels and how this understanding can be harnessed for potential disease interventions.

Daya Mena, B.A.

Daya Mena completed her BA in Biomedical Sciences at Hampshire College in 2019, while concentrating on Biomedical and Biomathematical Sciences. Her undergraduate thesis was on using mathematical modeling to predict the impact of gene editing on HIV therapy. Alongside her studies, Daya served on the...

Sooyeon Jo, Ph.D.

Sooyeon Jo is an electrophysiologist, molecular, and cell biologist. She received PhD from Gwangju Institute Science and Technology (GIST) in South Korea. She was interested in modulation of ion channels by cytosolic regulatory proteins which was characterized by molecular biological, cell...